Krónikus obstruktív tüdőbetegség (COPD): vizsgálatok itt: Új-Zéland
8 trials · From ClinicalTrials.gov, checked 2026. november 11.. Ask the study team whether a trial fits you.
- 3. fázisTaking peopleEfficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
- Where
- Auckland, Christchurch, Ebdentown
- Életkor
- 40 év to 80 év
- People
- 942 worldwide
- Run by
- Sanofi
See details and how to joinNCT07190222 · EU 2024-518213-25-00 - 3. fázisTaking peopleA Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)
- Where
- Auckland, Hamilton West, Tauranga
- Életkor
- 40 év to 80 év
- People
- 990 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06878261 · EU 2024-517457-27-00 - 3. fázisTaking peopleDepemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)
- Where
- Auckland, Christchurch, Ebdentown, Hamilton, Rotorua, Takapuna
- Életkor
- 40 év to 80 év
- People
- 961 worldwide
- Run by
- GlaxoSmithKline
See details and how to joinNCT06961214 · EU 2024-520417-41-00 - 3. fázisTaking peopleeValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation
- Where
- Ebdentown, Rotorua
- Életkor
- 40 év to 75 év
- People
- 1196 worldwide
- Run by
- GlaxoSmithKline
See details and how to joinNCT07177339 · EU 2025-521108-23-00 - 1. fázisTaking peopleA Study of BBT002 in Healthy Volunteers (HVs) and in Adult Patients With Chronic Obstructive Pulmonary Disease (COPD) or Chronic Rhiosininusitis With Nasal Polyps (CRSwNP)
- Where
- Pukekohe, Rotorua, Wellington
- Életkor
- 18 év to 80 év
- People
- 286 worldwide
- Run by
- Bambusa Therapeutics
See details and how to joinNCT06944925 · EU 2025-523142-28-00 - 3. fázisCsak meghívásosLong Term Safety of Alpha1-Proteinase Inhibitor in Subjects With Alpha1 Antitrypsin Deficiency
- Where
- Auckland, Christchurch, Hamilton
- Életkor
- 20 év to 72 év
- People
- 290 worldwide
- Run by
- Grifols Therapeutics LLC
See details and how to joinNCT02796937 - No phaseNot yet taking people in Új-ZélandThe Effect of Mask Design on Ventilation Parameters in COPD and OHS Patients on Long-term Home Non-invasive Ventilation. An Experimental Study.
- Where
- Auckland
- Életkor
- 18 év and over
- People
- 20
- Run by
- Fisher and Paykel Healthcare
See details and how to joinNCT06972589 - No phaseTaking peopleAssessment of Breathing Pattern During NIV
- Where
- Auckland
- Életkor
- 18 év and over
- People
- 40
- Run by
- Fisher and Paykel Healthcare
See details and how to joinNCT06682286